University Products' anaplasmosis vaccine protects cattle nationwide

Company’s vaccine has been available for over two decades.

October 2, 2024

3 Min Read
Getty Images

Recent developments in bovine anaplasmosis research have sparked excitement among cattle producers, but there has also been confusion surrounding the current state of vaccine availability. University Products, a longstanding leader in the field of bovine health, has been providing an effective anaplasmosis vaccine for over two decades. This tried-and-true solution offers protection against the disease, which affects cattle nationwide.

"There's a misperception that there are no effective vaccines for anaplasmosis currently available, but this is simply not true," said Gene Luther of University Products. "Our vaccine has been providing consistent, reliable protection for years, and it has helped countless producers manage this devastating disease and save money."

Proven efficacy in the field

A recent announcement suggests that a newly developed vaccine could soon offer protection from bovine anaplasmosis. And while any advancements in combating the disease are welcome, University Products remains confident in its own vaccine's superior track record.

Luther emphasized the importance of clear communication within the industry: "We welcome innovation and new research, but it's critical to ensure that producers aren't misled. Our vaccine gives great protection against anaplasmosis, and it is widely available now – not just possibly sometime in the future."

The University Products vaccine has been used by producers across the country, offering a long-term solution through an established vaccination schedule. Unlike unproven treatments still in development, University Products' vaccine has years of real-world application, minimizing symptoms in infected animals and reducing cattle deaths.

Cost-effective and easy to use

In addition to its reliability, the University Products vaccine is cost-effective and straightforward to administer. With just two doses in the first year and an annual booster, producers can easily incorporate the vaccine into their seasonal cattle-health management plans.

"Producers are facing a perfect storm of rising costs and growing disease threats," said Luther. "Our vaccine provides a practical, sustainable solution that allows them to focus on other critical aspects of their operations."

Addressing the economic impact

The U.S. beef industry loses more than $1 billion each year due to bovine anaplasmosis. Symptoms range from anemia and jaundice to decreased milk production and abortion, all of which significantly affect the productivity and profitability of livestock. While there is optimism around new treatments, there is no need to wait for future developments when University Products already offers a solution.

"Our vaccine has consistently proven to be one of the most economical approaches to mitigating these devastating losses," said Luther. "And our goal is to continue supporting producers with a product that's backed by over 20 years of success."

Looking forward

As research continues into new treatments for bovine anaplasmosis, University Products remains committed to providing its proven vaccine to the cattle industry. The company encourages producers to explore the full range of solutions available today, rather than waiting for trials that are still in development.

"It's important that cattle producers know they have an effective, widely available option now," Luther concluded. "We will continue to lead the charge in providing sustainable, reliable solutions that safeguard the industry from this costly disease."

Subscribe to Our Newsletters
BEEF Magazine is the source for beef production, management and market news.

You May Also Like